346 related articles for article (PubMed ID: 12124490)
21. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of Epstein-Barr virus infection and childhood lymphoma].
Xie ZD; Wang L; Lu D; Zhou CJ; Shen KL
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):365-7. PubMed ID: 18953837
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
[TBL] [Abstract][Full Text] [Related]
25. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells.
Dinand V; Dawar R; Arya LS; Unni R; Mohanty B; Singh R
Eur J Cancer; 2007 Jan; 43(1):161-8. PubMed ID: 17113770
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus infection is not associated with fibroadenomas of the breast in immunosuppressed patients after organ transplantation.
Lau SK; Chen YY; Berry GJ; Yousem SA; Weiss LM
Mod Pathol; 2003 Dec; 16(12):1242-7. PubMed ID: 14681325
[TBL] [Abstract][Full Text] [Related]
28. Investigation of Epstein-Barr virus in breast carcinomas in Tunisia.
Hachana M; Amara K; Ziadi S; Romdhane E; Gacem RB; Trimeche M
Pathol Res Pract; 2011 Nov; 207(11):695-700. PubMed ID: 22024152
[TBL] [Abstract][Full Text] [Related]
29. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
30. Childhood Hodgkin's disease in the United States: an analysis of histologic subtypes and association with Epstein-Barr virus.
Andriko JA; Aguilera NS; Nandedkar MA; Abbondanzo SL
Mod Pathol; 1997 Apr; 10(4):366-71. PubMed ID: 9110300
[TBL] [Abstract][Full Text] [Related]
31. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
32. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.
Sleckman BG; Mauch PM; Ambinder RF; Mann R; Pinkus GS; Kadin ME; Sherburne B; Perez-Atayde A; Thior I; Mueller N
Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1117-21. PubMed ID: 9865430
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
[TBL] [Abstract][Full Text] [Related]
35. [Detection of Epstein-Barr virus in lymphoproliferative diseases by in situ hybridization].
Xia C; Liu F; Sun Y
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):267-9. PubMed ID: 11038755
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
37. Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China.
Han AJ; Xiong M; Zong YS
Am J Clin Pathol; 2000 Aug; 114(2):220-6. PubMed ID: 10941337
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
[TBL] [Abstract][Full Text] [Related]
39. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
Murray PG; Swinnen LJ; Flavell JR; Ragni MV; Baumforth KR; Toomey SM; Filipovich AH; Lowe D; Schnell CS; Johl J; Gulley M; Young LS; Ambinder RF
Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226
[TBL] [Abstract][Full Text] [Related]
40. A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection.
Huh J; Park C; Juhng S; Kim CE; Poppema S; Kim C
Cancer; 1996 Mar; 77(5):949-55. PubMed ID: 8608489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
